Xtl Biopharmaceuticals (XTLB) Share-based Compensation (2013 - 2016)
Xtl Biopharmaceuticals (XTLB) recorded Share-based Compensation of $346,000 in the year ended Dec 31, 2025, up 31.1% from $264,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Share-based Compensation (2013 - 2016) Analysis & Trends
Starting with the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Share-based Compensation history includes 7 years.
- Annual Share-based Compensation has a five-year compound annual growth rate of 46.7% (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 is the highest annual Share-based Compensation in data going back to the year ended Dec 31, 2009.
- Per Business Quant data, XTLB's Share-based Compensation was $264,000 in the year ended Dec 31, 2024, $3,000 in the year ended Dec 31, 2023 (-78.6%), $14,000 in the year ended Dec 31, 2022 (-62.2%) and $37,000 in the year ended Dec 31, 2021 (-27.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 86,000.00 |
| Dec 31, 2015 | 29,000.00 |
| Sep 30, 2015 | 36,000.00 |
| Jun 30, 2015 | 37,000.00 |
| Dec 31, 2014 | 28,000.00 |
| Sep 30, 2014 | 48,000.00 |
| Jun 30, 2014 | 65,000.00 |
| Mar 31, 2014 | 137,000.00 |
| Dec 31, 2013 | -78,000.00 |
| Sep 30, 2013 | 13,000.00 |
| Jun 30, 2013 | 389,000.00 |
| Mar 31, 2013 | 446,000.00 |
API Access
Xtl Biopharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();